Brainstorm Cell Therapeutics Inc. (BCLI)
OTCMKTS
· Delayed Price · Currency is USD
0.930
-0.030 (-3.12%)
Jun 26, 2026, 3:54 PM EST
Brainstorm Cell Therapeutics Employees
Brainstorm Cell Therapeutics had 20 employees as of December 31, 2025. The number of employees decreased by 7 or -25.93% compared to the previous year.
Employees
20
Change (1Y)
-7
Growth (1Y)
-25.93%
Revenue / Employee
n/a
Profits / Employee
-$503,684
Market Cap
10.26M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Adaptimmune Therapeutics | 272 |
| Reviva Pharmaceuticals Holdings | 14 |
| Synlogic | 1 |
| NKGen Biotech | 26 |
| Zeo ScientifiX | 20 |
| Galera Therapeutics | 3 |
| Inhibitor Therapeutics | 8 |
Brainstorm Cell Therapeutics News
- 27 days ago - BrainStorm Cell Therapeutics Announces Publication Calling for Updated FDA Approaches to ALS, Rare Diseases and Regenerative Medicine - PRNewsWire
- 4 weeks ago - Lunai Bioworks and BrainStorm launch foundation for neurological diseases - TheFly
- 4 weeks ago - BrainStorm Cell Therapeutics Appoints Former FDA Associate Commissioner Peter J. Pitts to Board of Directors - PRNewsWire
- 5 weeks ago - Brainstorm Cell Therapeutics Registration statement: Registration filing - Filings
- 5 weeks ago - BrainStorm Cell Therapeutics Announces Aggregate of $400,000 in Private Placements Priced at Premium to Market - PRNewsWire
- 6 weeks ago - BrainStorm Cell Therapeutics Announces First Quarter 2026 Financial Results and Provides Corporate Update - PRNewsWire
- 6 weeks ago - Brainstorm Cell Therapeutics Quarterly report: Q1 2026 - Filings
- 6 weeks ago - Brainstorm Cell Therapeutics Earnings release: Q1 2026 - Filings